Skip to main content
OpenTrials
Completed

NCT Number: NCT00000268

Cocaine Abuse and Attention Deficit Disorder - 3

The purpose of this study is to evaluate cocaine abuse and Attention Deficit Disorder

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year–55 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

New York State Psychiatric Institute

New York, 10032, United States

About this study

To evaluate the safety and efficacy of methylphenidate and bupropion in treating individuals with adult Attention Deficit Disorder.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

current adult ADHD current cocaine dependence

Exclusion criteria

no current major depression

Treatment and study plan

bupropion

Drug

Primary outcomes

  1. Side effects

  2. Craving

  3. Drug use

  4. ADHD symptoms

  5. Improvement in functioning

  6. Tolerability

Sponsors and collaborators

Lead sponsor

National Institute on Drug Abuse (NIDA)

Nih

Collaborators

  • New York State Psychiatric Institute

Registry information

Official study title

Cocaine Abuse and Attention Deficit Disorder

Important dates

Study start
1995
Study completion
1998
First posted
Sep 21, 1999
Registry last updated
Jan 12, 2017

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.